Dollars for Docs

How Industry Dollars Reach Your Doctors

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

Guam »
PAUL C COTY
Is This Your Doctor?

PAUL C COTY

Listed Specialty: Hematology & Oncology
543 CHALAN GUMA YU'OS, TAMUNING, GU, 96913-3630
Is This Your Doctor?

DR. PAUL COTY,
Yearly Payment Breakdown:

2018 Payments At a Glance

21

payments

$712

payment total

14

companies paid this doctor

Payment Calendar in 2018

This doctor received a payment on days in 2018.

Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.

2018

Types of Payments in 2018

Category Payments Payment Value
Food and Beverage
21 $712

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments
DARZALEX

drug

$125
IMBRUVICA

drug

$125
ADCETRIS

drug

$102
JAKAFI

drug

$101
KEYTRUDA

drug

$95
AVASTIN

drug

$41
OPDIVO

drug

$30
GILOTRIF

drug

$22
ALECENSA

drug

$21
TECENTRIQ

drug

$21
PERJETA

drug

$21
AFINITOR

drug

$20
SANDOSTATIN LAR

drug

$20
JADENU

drug

$20
PROMACTA

drug

$20
KYPROLIS

drug

$19
Payments with no listed product

N/A

$19
POMALYST

drug

$18
IDHIFA

drug

$17
SPRYCEL

drug

$16
TAGRISSO

drug

$16
XERMELO

drug

$15
MEKINIST

drug

$15
TAFINLAR

drug

$15
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details in 2018

When How Much Related To What For From Third Party Payee
Mar 17, 2018 $125 IMBRUVICA DARZALEX Food and Beverage JANSSEN SCIENTIFIC AFFAIRS, LLC
Apr 5, 2018 $101 JAKAFI Food and Beverage INCYTE CORPORATION
Mar 6, 2018 $95 KEYTRUDA Food and Beverage MERCK SHARP & DOHME CORPORATION
May 31, 2018 $78 ADCETRIS Food and Beverage SEATTLE GENETICS, INC.
Feb 16, 2018 $24 ADCETRIS Food and Beverage SEATTLE GENETICS, INC.
Jun 28, 2018 $22 GILOTRIF Food and Beverage BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Mar 6, 2018 $21 AVASTIN ALECENSA TECENTRIQ Food and Beverage GENENTECH USA, INC.
May 22, 2018 $21 PERJETA Food and Beverage GENENTECH USA, INC.
Feb 8, 2018 $21 AVASTIN Food and Beverage GENENTECH USA, INC.
Jan 30, 2018 $20 AFINITOR SANDOSTATIN LAR Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Feb 27, 2018 $20 JADENU PROMACTA Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
Nov 15, 2018 $19 KYPROLIS Food and Beverage AMGEN INC.
Mar 8, 2018 $19 No Listed Product Food and Beverage GILEAD SCIENCES INC
May 16, 2018 $18 POMALYST Food and Beverage CELGENE CORPORATION
May 9, 2018 $17 IDHIFA Food and Beverage AGIOS PHARMACEUTICALS, INC.
Jan 5, 2018 $16 SPRYCEL Food and Beverage E.R. SQUIBB & SONS, L.L.C.
Jun 26, 2018 $16 TAGRISSO Food and Beverage ASTRAZENECA PHARMACEUTICALS LP
Jan 23, 2018 $15 XERMELO Food and Beverage LEXICON PHARMACEUTICALS, INC.
Jan 25, 2018 $15 OPDIVO Food and Beverage E.R. SQUIBB & SONS, L.L.C.
Apr 17, 2018 $15 MEKINIST TAFINLAR Food and Beverage NOVARTIS PHARMACEUTICALS CORPORATION
May 24, 2018 $14 OPDIVO Food and Beverage E.R. SQUIBB & SONS, L.L.C.
See this doctor’s Open Payments page →

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.